Equities

Amniotics AB (publ)

Amniotics AB (publ)

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)0.005
  • Today's Change0.000 / 6.38%
  • Shares traded34.91k
  • 1 Year change-70.85%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Amniotics AB (publ) (AMNI:STO) closed at 0.005, 316.67% above the 52 week low of 0.0012 set on May 28, 2024.
52-week range
Today
0.0012May 28 20240.0456Nov 20 2023
Open0.0046
High0.005
Low0.0046
Bid0.0049
Offer0.005
Previous close0.0047
Average volume2.00m
Shares outstanding2.73bn
Free float1.36bn
P/E (TTM)--
Market cap13.67m SEK
EPS (TTM)-0.0374
SEK
Data delayed at least 15 minutes, as of Sep 20 2024 17:00 BST.
More ▼

Events & Activity

  • AMNI:STO trading volume exceeds daily average by +79.35%
  • AMNI:STO price moved over +6.52% to 0.0049
  • AMNI:STO price rises above 15-day moving average to 0.0049 at 04:50 BST
  • AMNI:STO price falls below 15-day moving average to 0.0046 at 04:28 BST
  • AMNI:STO price rises above 15-day moving average to 0.0049 at 04:40 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.